About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 482 record(s)
Req # A-2023-000142
Adverse Drug Reactions (ADRs). Report numbers: E2B_05626567, E2B_06091610.Organization: Health Canada
July 2023
Req # A-2023-000144
Adverse Drug Reactions (ADRs). Report numbers: 001012008, E2B_05973298, 001017661, E2B_05771578, 001010359, E2B_05968917, E2B_05970251, E2B_05785121.Organization: Health Canada
July 2023
Req # A-2023-000145
Adverse Drug Reactions (ADRs). Report numbers: 000960475, 000970044, E2B_04193198, E2B_04318483, E2B_04476673, E2B_04477019, E2B_04551382, E2B_04608126, 000967445, 000975140.Organization: Health Canada
July 2023
Req # A-2023-000161
Adverse Drug Reactions (ADRs) for TEMODAL. Report numbers: E2B_03072550, E2B_02069473, E2B_02600423, E2B_02839770, E2B_03200196.Organization: Health Canada
July 2023
Req # A-2023-000163
Adverse Drug Reactions (ADRs) for ENTYVIO. Report numbers: E2B_06130187, E2B_06181182, E2B_06183045. ADRs for ONDANSETRON. Report numbers: 001031515, E2B_06197292, E2B_06120653. ADRs for PANTOPRAZOLE SODIUM. Report numbers: E2B_06138078,…Organization: Health Canada
July 2023
Req # A-2023-000174
Adverse Drug Reactions (ADRs). Report numbers: 001007986, E2B_06132172.Organization: Health Canada
July 2023
Req # A-2023-000192
Adverse Drug Reactions (ADRs). Report numbers: 000716626, E2B_02102635, E2B_03856343, E2B_02295853, E2B_01234488.Organization: Health Canada
July 2023
Req # A-2023-000198
Adverse Drug Reactions (ADRs). Report numbers: 001008002, E2B_05687144.Organization: Health Canada
July 2023
Req # A-2023-000218
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102624-326.Organization: Health Canada
July 2023
Req # A-2023-000220
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101267-73.Organization: Health Canada
July 2023